Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read moreSupporting fusion energy development in the UK
CEO Spotlight: Laura Knight, COO, The Smarter Food Company
Cytoseek raises £3.57m ($5m) to advance its mission to develop the next generation of cell therapies for cancer
Experienced CRO and Biotech executive, Dr Lloyd Payne, joins Perfectus Biomed Group as non-executive director
Advanced Materials in the UK: Investment opportunities
Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease
University of Birmingham spin-out secures £800k for point of care diagnostics platform
CEO Spotlight: Fiona Marshall
Staying agile in early-stage deep technology companies
Investing in UK Space Technology
Virtual business: completing a merger online
Supporting UK agritech innovation
Tips for first-time fundraising
From academia to start-up: how to build a successful spin-out
Financial management in a crisis: how can early stage technology companies survive a pandemic
New analysis confirms value of UKI2S investing public money to commercialise public science
Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read more